As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...

The stroke was a wake-up call for the SLMD Skincare founder, who told E! News that she is treating and monitoring her blood ...

April is Parkinson’s Awareness Month, and one La Crosse man is sharing his story in a deeply personal way—hoping to raise ...

Blue Jays veteran is reportedly feeling better after being diagnosed with tough injury originally appeared on The Sporting ...

Small errors in technique, like taking the reading over your clothes, can significantly affect readings and lead to incorrect ...

These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...

Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with ...

Detailed tests and scans eventually revealed the cause - an advanced stage of clear cell ovarian cancer. For another patient, Michelle (not her real name), aged 49, the road to diagnosis came in late ...

Cancer treatment has improved greatly over the years, allowing more people to survive and live longer lives. While this is a ...

Shingles isn’t just a painful rash and nerve pain. It’s also linked with a higher risk of serious cardiovascular events, including heart attack and stroke, especially in the weeks to months after ...